GSK Clinical Trials [clinicaltrials_resource:482ca15ed5613e7d70d0185ac9204ca5]
clinicaltrials:NCT00038961clinicaltrials:NCT00040664Prevention Of Recurrence Of Atrial Fibrillation [clinicaltrials:NCT00041496]ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) [clinicaltrials:NCT00041509]Pediatric Epilepsy Trial in Subjects 1-24 Months [clinicaltrials:NCT00043875]Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug [clinicaltrials:NCT00043901]Pediatric Epilepsy Study in Subjects 1-24 Months [clinicaltrials:NCT00044278]A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors [clinicaltrials:NCT00046111]Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. [clinicaltrials:NCT00051103]clinicaltrials:NCT00056407An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder [clinicaltrials:NCT00057213]An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder [clinicaltrials:NCT00057226]A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer [clinicaltrials:NCT00058526]Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension [clinicaltrials:NCT00060918]Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension [clinicaltrials:NCT00060931]GW572016 For Treatment Of Refractory Metastatic Breast Cancer [clinicaltrials:NCT00062686]clinicaltrials:NCT00064428Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00065182]Depression Study In Elderly Patients [clinicaltrials:NCT00067444]Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy [clinicaltrials:NCT00067457]Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy [clinicaltrials:NCT00067561]Bipolar Study in Adults at Least 18 Years of Age [clinicaltrials:NCT00067938]A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics [clinicaltrials:NCT00067951]Study Of AVANDAMET With Or Without Insulin In Type II Diabetes Mellitus Patients [clinicaltrials:NCT00069836]clinicaltrials:NCT00071487clinicaltrials:NCT00071812clinicaltrials:NCT00073008clinicaltrials:NCT00073528clinicaltrials:NCT00075270Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia [clinicaltrials:NCT00086593]Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) [clinicaltrials:NCT00086658]GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults [clinicaltrials:NCT00089986]clinicaltrials:NCT00089999clinicaltrials:NCT00090103Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00092924]Major Depressive Disorder In The Elderly [clinicaltrials:NCT00093288]Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) [clinicaltrials:NCT00094848]Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis [clinicaltrials:NCT00097331]Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome [clinicaltrials:NCT00097370]A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C [clinicaltrials:NCT00097435]
overall official [clinicaltrials_vocabulary:overall-official]
GSK Clinical Trials [clinicaltrials_resource:482ca15ed5613e7d70d0185ac9204ca5]
Bio2RDF identifier
482ca15ed5613e7d70d0185ac9204ca5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:482ca15ed5613e7d70d0185ac9204ca5
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
GSKClinicalSupportHD@gsk.com
last name [clinicaltrials_vocabulary:last-name]
GSK Clinical Trials
phone [clinicaltrials_vocabulary:phone]
1-866-435-7343
866-435-7343
877-379-3718
877-936-6778
88-435-7343
888-435-7343
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:482ca15ed5613e7d70d0185ac9204ca5
title
GSK Clinical Trials
@en
type
label
GSK Clinical Trials [clinicaltrials_resource:482ca15ed5613e7d70d0185ac9204ca5]
@en